With its collaborators Genentech, Icelandic company DeCode Genetics has found a rare gene variant that marks protection against both Alzheimer's disease and general cognitive decline. This ...

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery -- our ...

DeCode scientists reported yesterday that people who inherit two copies of the gene – one from each parent – are more than twice as likely to develop diabetes as those who don’t carry any copies.

DeCode Genetics Inc. scientists mapped a gene linked to rheumatoid arthritis, a step that could aid development of medicines and diagnostic tests.

News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.

The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. <DCGN.O>.

Scholars develop new technology to decode gene transcription facilitating discovery of targeted therapy drugs by Hong Kong Baptist University ...

Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit.

Decode Genetics Inc. and Roche Holding Ltd. will disclose Wednesday that they have made progress in turning two earlier gene discoveries into potential treatments for schizophrenia and the ...